185 related articles for article (PubMed ID: 25097724)
1. Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cells.
Gothelf Y; Abramov N; Harel A; Offen D
Clin Transl Med; 2014; 3():21. PubMed ID: 25097724
[TBL] [Abstract][Full Text] [Related]
2. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
3. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Cudkowicz ME; Lindborg SR; Goyal NA; Miller RG; Burford MJ; Berry JD; Nicholson KA; Mozaffar T; Katz JS; Jenkins LJ; Baloh RH; Lewis RA; Staff NP; Owegi MA; Berry DA; Gothelf Y; Levy YS; Aricha R; Kern RZ; Windebank AJ; Brown RH
Muscle Nerve; 2022 Mar; 65(3):291-302. PubMed ID: 34890069
[TBL] [Abstract][Full Text] [Related]
4. miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors.
Gothelf Y; Kaspi H; Abramov N; Aricha R
Stem Cell Res Ther; 2017 Nov; 8(1):249. PubMed ID: 29116031
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
6. Various detailed characteristics of a new enhanced neurotrophic factor secreting rat derived bone marrow mesenchymal stem cells and its preliminary application in rat models of ischemic stroke.
Jiang F; Zhou H; Cheng Y; He Z; Meng P; Sun K; Wang P; Han X; Wang L; Yang M; Jiang N; Liu Y; Yuan C; Yang Q; An Y
Exp Cell Res; 2022 Jul; 416(1):113140. PubMed ID: 35436472
[TBL] [Abstract][Full Text] [Related]
7. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
Berry JD; Cudkowicz ME; Windebank AJ; Staff NP; Owegi M; Nicholson K; McKenna-Yasek D; Levy YS; Abramov N; Kaspi H; Mehra M; Aricha R; Gothelf Y; Brown RH
Neurology; 2019 Dec; 93(24):e2294-e2305. PubMed ID: 31740545
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease.
Sadan O; Bahat-Stromza M; Barhum Y; Levy YS; Pisnevsky A; Peretz H; Ilan AB; Bulvik S; Shemesh N; Krepel D; Cohen Y; Melamed E; Offen D
Stem Cells Dev; 2009 Oct; 18(8):1179-90. PubMed ID: 19243240
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
[TBL] [Abstract][Full Text] [Related]
11. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
[TBL] [Abstract][Full Text] [Related]
12. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
[TBL] [Abstract][Full Text] [Related]
13. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.
Sun H; Bénardais K; Stanslowsky N; Thau-Habermann N; Hensel N; Huang D; Claus P; Dengler R; Stangel M; Petri S
PLoS One; 2013; 8(9):e72926. PubMed ID: 24069165
[TBL] [Abstract][Full Text] [Related]
15. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
[TBL] [Abstract][Full Text] [Related]
17. Co-culture with neurotrophic factor secreting cells induced from adipose-derived stem cells: promotes neurogenic differentiation.
Razavi S; Razavi MR; Kheirollahi-Kouhestani M; Mardani M; Mostafavi FS
Biochem Biophys Res Commun; 2013 Oct; 440(3):381-7. PubMed ID: 24064351
[TBL] [Abstract][Full Text] [Related]
18. Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress.
Yust-Katz S; Fisher-Shoval Y; Barhum Y; Ben-Zur T; Barzilay R; Lev N; Hod M; Melamed E; Offen D
Cytotherapy; 2012 Jan; 14(1):45-55. PubMed ID: 22040110
[TBL] [Abstract][Full Text] [Related]
19. Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells.
Alagesan S; Sanz-Nogués C; Chen X; Creane M; Ritter T; Ceredig R; O'Brien T; Griffin MD
Immunol Cell Biol; 2018 May; 96(5):536-548. PubMed ID: 29446493
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantations in ALS Patients by Investigating Patients' Specific Immunological and Biochemical Biomarkers.
Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Farkhad NK; Khodadoust MA; Tavakol-Afshari J
Diseases; 2024 May; 12(5):. PubMed ID: 38785754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
